Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/21/14 → 1/21/17 |
Funding
- Merck Sharp & Dohme Corporation (Prot #MK8226-003)
Prot #MK8226-003: A Phase 1b Randomized, Double-Blinded, Placebo-Controlled Multiple Rising Dose Clinical Trial to Study the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics and Immunogenicity of Intravenous MK-8226 in Patients with Moderate to Severe
- Gordon, Kenneth B (PD/PI)
Project: Research project